# Lakepharma, Inc.

Canonical: https://abierto.us/vendors/lakepharma-inc-d9cemfl2zyb7

- UEI: D9CEMFL2ZYB7
- CAGE: 5LNN7
- Location: Belmont, CA
- Awards in window: 3 (4 transactions), -$5,994 obligated, July 31, 2024 to September 9, 2025

## Awarding agencies

- Department of the Navy: 1 awards, -$290
- National Institutes of Health: 2 awards, -$5,704

## Industries

- 325413 In-Vitro Diagnostic Substance Manufacturing: -$290
- 325414 Biological Product (except Diagnostic) Manufacturing: -$739
- 541380 Testing Laboratories and Services: -$4,965

## Competition

- Competed Under SAP: 2 awards
- Not Competed Under SAP: 1 awards

## Largest awards

- N3239818P0277 (purchase order): -$290, Naval Medical Research Center. Custom 1 - Gene Synthesis Through. https://www.usaspending.gov/award/CONT_AWD_N3239818P0277_9700_-NONE-_-NONE-/
- 75N93020P01273 (purchase order): -$739, National Institutes of Health Niaid. Dna Scale-Up Sufficient for 0.5L Production (2DNA). https://www.usaspending.gov/award/CONT_AWD_75N93020P01273_7529_-NONE-_-NONE-/
- 75N95B20P00031 (purchase order): -$4,965, National Institutes of Health. FY20 Modification to Deobligate Unused Funds on Lines 2 and 4. https://www.usaspending.gov/award/CONT_AWD_75N95B20P00031_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/lakepharma-inc-d9cemfl2zyb7.